Abstract
The present work comprises the formulation and evaluation of losartan potassium with a view to developing and preparing a losartan potassium releasing system for transdermal applications. The aim of the study was to prepare the transdermal patch of drug using different blends of polymers. Transdermal patches of losartan potassium were prepared using ethyl cellulose (EC): polyvinyl pyrrolidone (PVP), Eudragit RL-100: Eudragit RS-100 and polyvinyl alcohol (PVA): polyvinyl pyrrolidone (PVP) using different ratios by the solvent casting technique. Physicochemical parameters like flexibility, thickness, smoothness, moisture content, hardness, and tensile strength were studied. The in vitro permeation study was carried out using a modified Keshery diffusion cell, and the formulation followed the Higuchi diffusion mechanism. The blood pressure lowering response of all formulations was studied using hypertension-induced rats by the chronic renal hypertension method. The formulation containing Eudragit RL-100: Eudragit RS-100 as polymers showed satisfactory drug release pattern (hydrophobic polymers) compared to combination of hydrophobic and hydrophilic polymers (EC: PVP) and PVA: PVP (hydrophilic polymers). The amount of drug release from formulations containing hydrophilic polymers and combination of both hydrophobic and hydrophilic polymers were found to be less in comparison to the patches of hydrophobic polymers.
LAY ABSTRACT: The aim of the present study was to prepare and evaluate the transdermal patch of drug using different polymers such as hydrophobic, combination of hydrophobic: hydrophilic, and hydrophilic. Losartan potassium (hydrophilic) is the antihypertensive drug used for lowering increased blood pressure. Transdermal patches of losartan potassium were prepared using different ratios of polymers by the solvent casting technique. The prepared patches were evaluated for their flexibility, thickness, smoothness, moisture content, hardness, and tensile strength. The in vitro permeation study was carried out using a diffusion cell. The blood lowering response of all formulations was studied using hypertension-induced rats. The formulation containing hydrophobic polymers showed a satisfactory drug release pattern compared to the combination of hydrophobic: hydrophilic polymers and the hydrophilic polymers. Hence, the present study reveals that formulation of hydrophilic drug (losartan potassium) withhydrophobic polymers exhibit good release properties as compared to that of hydrophilic polymers and combination of both hydrophobic and hydrophilic polymers.
- © PDA, Inc. 2012
PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.
If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing.
Full issue PDFs are for PDA members only.
Note to pda.org users
The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.
Log in using your username and password
Log in through your institution
Purchase access
patientACCESS
Jump to section
Related Articles
Cited By...
- No citing articles found.